Labcorp Holdings Inc. (LH)
NYSE: LH · Real-Time Price · USD
230.02
-1.65 (-0.71%)
At close: Mar 28, 2025, 4:00 PM
235.67
+5.65 (2.46%)
After-hours: Mar 28, 2025, 8:00 PM EDT
Labcorp Holdings Revenue
In the year 2024, Labcorp Holdings had annual revenue of $13.01B with 6.97% growth. Labcorp Holdings had revenue of $3.33B in the quarter ending December 31, 2024, with 9.76% growth.
Revenue (ttm)
$13.01B
Revenue Growth
+6.97%
P/S Ratio
1.48
Revenue / Employee
$185,841
Employees
70,000
Market Cap
19.25B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 13.01B | 847.30M | 6.97% |
Dec 31, 2023 | 12.16B | 297.70M | 2.51% |
Dec 31, 2022 | 11.86B | -1.27B | -9.68% |
Dec 31, 2021 | 13.14B | -842.40M | -6.03% |
Dec 31, 2020 | 13.98B | 2.42B | 20.98% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
UnitedHealth Group | 400.28B |
Johnson & Johnson | 88.82B |
Merck & Co. | 64.17B |
AbbVie | 56.33B |
AstraZeneca | 54.07B |
Novartis AG | 51.72B |
Eli Lilly and Company | 45.04B |
Thermo Fisher Scientific | 42.88B |
LH News
- 18 days ago - Labcorp Announces Acquisition of Select Assets of BioReference Health's Innovative Oncology and Related Clinical Testing Services Businesses - PRNewsWire
- 4 weeks ago - Labcorp Announces Clinical Availability of Liquid Biopsy Test to Guide Personalized Treatment Plans for Patients with Advanced Solid Tumors - PRNewsWire
- 6 weeks ago - Labcorp Holdings: Focus On Core Strengths For Future Growth, Initiate At 'Hold' - Seeking Alpha
- 7 weeks ago - Labcorp Holdings Inc. (LH) Q4 2024 Earnings Call Transcript - Seeking Alpha
- 7 weeks ago - Labcorp Q4 Earnings: Revenue And EPS Beat, Expects Strong 2025 Growth, Analyst Reiterates Outperform On Stable 2025 Outlook - Benzinga
- 7 weeks ago - Labcorp forecasts 2025 revenue above estimates on diagnostic test demand - Reuters
- 7 weeks ago - Labcorp Announces 2024 Fourth Quarter and Full Year Results - PRNewsWire
- 2 months ago - Labcorp to Speak at the 43rd Annual J.P. Morgan Healthcare Conference - PRNewsWire